Sanofi-Aventis SA and Regulus Therapeutics Inc have formed a global alliance to develop and commercialise medicines based on microRNA, a class of small ribonucleic acid molecules that regulate gene expression. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
